Traditionally, drug discovery relied heavily on trial and error, with long timelines and high costs. The introduction of ...

In an industry where 90 percent of drug candidates fail before reaching the market, a handful of startups are betting ...

Seven biotech unicorns are advancing AI-powered drug discovery and development—but must contend with a difficult investing ...

Discover Grok 4, the AI model redefining advanced reasoning and problem-solving. Explore its potential, challenges, and ...

Below are the most-read DIGITIMES Asia stories from July 7 to July 13, 2025. This week's top three highlights include China’s ...

Glenmark’s progress with a cancer treatment shows the potential of Indian pharma to move from generics to drug discovery. With tech-enabled therapies evolving fast, new inflection points spell a ...

In this week’s edition of InnovationRx, we look at how Daniel Nadler became a billionaire building a ChatGPT for doctors, big news from two Chinese biotech companies, what doctors think about AI and ...

The finish line for this year’s AI sprint is Las Vegas in December, when Garman will host his first full re:Invent conference as chief executive. He promises a “lot of agentic news” and hints at ...

The much-maligned 1995 cyberpunk film envisioned a world of tech addiction, brain implants, and AI companions—ideas that feel eerily relevant in today's world.

One of the biggest barriers to the adoption of any new biotechnology tool is validation and regulatory clarity.

The Silicon Valley entrepreneur has turned his body into a living experiment in a bid to reframe longevity as a solvable ...

Technology remains at the heart of most growth opportunities. Artificial intelligence and the data centers needed to house ...